DENVER, Mar 27, 2014 (BUSINESS WIRE) — An outbreak of the deadly Ebola virus in West Africa has promptedCorgenix Medical CorporationCONX -12.64% to extend its existing viral hemorrhagic fever (VHF)

rapid test development to include the Ebola virus. Corgenix has already developed and CE marked a rapid test for the Lassa fever virus, another member of the VHF group of viruses.

Leave a Reply

Your email address will not be published. Required fields are marked *

Help us improve the translation for your language

You can change any text by clicking on (press Enter after changing)